Optimization of Chitosan and Cellulose Acetate Phthalate Controlled Delivery of Methylprednisolone for Treatment of Inflammatory Bowel Disease

Swati Jagdale ¹ * , Apoorva Chandekar ¹

Cited by CrossRef: 4

1- Turanlı Y, Tort S, Acartürk F. Development and characterization of methylprednisolone loaded delayed release nanofibers. Journal of Drug Delivery Science and Technology. 2019;49:58 [Crossref]

2- Sajeevan A, Ramamurthy T, Solomon A. Vibrio cholerae virulence and its suppression through the quorum-sensing system . Critical Reviews in Microbiology. 2024;:1 [Crossref]

3- Mirzaeei S, Barfar D. Design and Development of Antibacterial/Anti-inflammatory Dual Drug-Loaded Nanofibrous Inserts for Ophthalmic Sustained Delivery of Gentamicin and Methylprednisolone: In Vitro Bioassay, Solvent, and Method Effects’ Evaluation. Adv Pharm Bull. 2022;12(3):531 [Crossref]

4- Zhao Y, Xu C, Liu Q, Lei X, Deng L, Wang F, Yang J. pH-responsive interface conversion efficient oral drug delivery platform for alleviating inflammatory bowel disease. Front Chem. 2024;12 [Crossref]

5- Nieto González N, Cerri G, Molpeceres J, Cossu M, Rassu G, Giunchedi P, Gavini E. Surfactant-Free Chitosan/Cellulose Acetate Phthalate Nanoparticles: An Attempt to Solve the Needs of Captopril Administration in Paediatrics. Pharmaceuticals. 2022;15(6):662 [Crossref]